학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 74건 | 목록 1~10
Academic Journal
Sun R; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Lerousseau M; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Briend-Diop J; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Routier E; Dermatology Unit, Department of Medicine, Gustave Roussy, Villejuif, France.; Université Paris Saclay, Inserm U981, Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.; Roy S; Dermatology Unit, Department of Medicine, Gustave Roussy, Villejuif, France.; Université Paris Saclay, Inserm U981, Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.; Henry T; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Imaging Department, Gustave Roussy, Villejuif, France.; Ka K; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Jiang R; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Temar N; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Carré A; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Laville A; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Hamaoui A; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Laurent PA; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Rouyar A; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Robert C; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.; Robert C; Dermatology Unit, Department of Medicine, Gustave Roussy, Villejuif, France.; Université Paris Saclay, Inserm U981, Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.; Deutsch E; Department of Radiation Oncology, Gustave Roussy, Villejuif, France eric.deutsch@gustaveroussy.fr.; Université Paris Saclay, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Villejuif, France.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Sun R; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; Paris-Saclay University Faculty of Medicine, Le Kremlin-Bicetre, Île-de-France, France.; Sundahl N; Department of Radiation Oncology, University Hospital Ghent, Gent, Oost-Vlaanderen, Belgium.; Hecht M; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Putz F; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Lancia A; Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy.; Rouyar A; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; Milic M; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; Carré A; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; Battistella E; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; Alvarez Andres E; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; TheraPanacea, Paris, France.; Niyoteka S; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; Romano E; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.; Louvel G; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.; Durand-Labrunie J; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.; Bockel S; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; Paris-Saclay University Faculty of Medicine, Le Kremlin-Bicetre, Île-de-France, France.; Bahleda R; Drug Development Department, Gustave Roussy, Villejuif, Île-de-France, France.; Robert C; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; Boutros C; Departement of Medicine, Gustave Roussy, Villejuif, Île-de-France, France.; Vakalopoulou M; CentraleSupélec, Gif-sur-Yvette, Île-de-France, France.; Paragios N; TheraPanacea, Paris, France.; CentraleSupélec, Gif-sur-Yvette, Île-de-France, France.; Frey B; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Soria JC; Departement of Medicine, Gustave Roussy, Villejuif, Île-de-France, France.; Massard C; Paris-Saclay University Faculty of Medicine, Le Kremlin-Bicetre, Île-de-France, France.; Drug Development Department, Gustave Roussy, Villejuif, Île-de-France, France.; Ferté C; Departement of Medicine, Gustave Roussy, Villejuif, Île-de-France, France.; Fietkau R; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Ost P; Department of Radiation Oncology, University Hospital Ghent, Gent, Oost-Vlaanderen, Belgium.; Gaipl U; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Deutsch E; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France eric.deutsch@gustaveroussy.fr.; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.; Paris-Saclay University Faculty of Medicine, Le Kremlin-Bicetre, Île-de-France, France.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Rouyar A; Department of Biology, University of Washington, Seattle, WA, United States.; Patil AA; Department of Biology, University of Washington, Seattle, WA, United States.; Leon-Noreña M; Department of Biology, University of Washington, Seattle, WA, United States.; Li M; Division of Biological Sciences, Section of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States.; Coutinho-Abreu IV; Division of Biological Sciences, Section of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States.; Akbari OS; Division of Biological Sciences, Section of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States.; Riffell JA; Department of Biology, University of Washington, Seattle, WA, United States.
Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101549006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-042X (Print) Linking ISSN: 1664042X NLM ISO Abbreviation: Front Physiol Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Rouyar, A.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어